Followers | 216 |
Posts | 9365 |
Boards Moderated | 1 |
Alias Born | 02/20/2015 |
Thursday, March 07, 2019 1:10:59 PM
0.0003 +0.0001 (+50.00%) 11:15 ET [OTC US]
QUOTE OVERVIEW for Thu, Mar 7th, 2019 Alerts Watch Help
Day Low
0.0003
Day High
0.0003
Open 0.0003
Previous Close 0.0002
Volume 100,000
Avg Vol 8,022,150
Stochastic %K 50.00%
Weighted Alpha -10.61
5-Day Change unch (unch)
52-Week Range 0.0001 - 0.0004
1D5D1M3M6M1Y5Y20Y
Use regions/landmarks to skip ahead to chart and navigate between data series
Chart
Long description.
The chart shows Daily data for the symbol GGSM.
Structure.
Combination chart with 2 data series.
The chart has 2 X axes displaying Time and navigator-x-axis
The chart has 2 Y axes displaying symbol GGSM and navigator-y-axis
Chart graphic.
Dec 17
Jan 28
Feb 25
0.0000
0.0001
0.0002
0.0003
0.0004
0.0005
0.0003
Fundamentals
Market Capitalization, $K N/A
Shares Outstanding, K N/A
Annual Sales, $ 0 K
Annual Income, $ 0 K
36-Month Beta N/A
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Price/Earnings ttm N/A
Earnings Per Share ttm N/A
Most Recent Earnings N/A on N/A
Next Earnings Date N/A
Annual Dividend & Yield N/A (0.00%)
Most Recent Dividend N/A on N/A
SECTORS:
Free Barchart Webinars! Live educational sessions using site features to explore today's markets. Sign Up.
Price Performance
Period Period Low Period High Performance
1-Month
0.0002 +50.00%
on 03/06/19
Period Open: 0.0003
0.0004 -25.00%
on 02/28/19
unch (unch)
since 02/07/19
3-Month
0.0001 +200.00%
on 01/30/19
Period Open: 0.0002
0.0004 -25.00%
on 02/28/19
+0.0001 (+50.00%)
since 12/07/18
52-Week
0.0001 +200.00%
on 01/30/19
Period Open: 0.0002
0.0004 -25.00%
on 02/28/19
+0.0001 (+50.00%)
since 03/07/18
Barchart Technical Opinion
BUY
The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.
Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.
Recent GGSM News
- Shares Rip on Earnings Results • AllPennyStocks.com • 05/18/2023 04:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM